46.46.Z - Wholesale trade of pharmaceutical and medical products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
47.92.Z - Intermediary retail sale, specialized
70.20.Z - Business and management consultancy activities
72.10.Z - Scientific research and development in natural and technical sciences
96.99.Z - Other individual services not classified elsewhere
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,1 | -0,2 | -0,8 | -246,2 |
EBITDA | 5,9 | -0,2 | -0,7 | -181,4 |
Short time liabilities | 0,1 | 0,3 | 0,3 | -0,4 |
Equity capital | -0,1 | 0 | 0,8 | 7138,9 |
Operating profit (EBIT) | 5,5 | -0,2 | -0,7 | -194,3 |
Assets | 0,2 | 0,4 | 1,2 | 198,8 |
Net profit (loss) | 3,8 | -0,2 | -0,8 | -249,6 |
Cash | 0 | 0 | 0,4 | 5213 |
Net income from sale | 1,2 | 0,1 | 1,6 | 2707,6 |
Liabilities and provisions for liabilities | 0,2 | 0,4 | 0,4 | 0,9 |
Working assets | 0,2 | 0,3 | 0,8 | 171,4 |
Depreciation | 0,4 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -6451,3 | -1999,5 | -96,6 | 1902,9 |
Equity capital to total assets | -37,2 | 2,8 | 67,2 | 64,4 |
Gross profit margin | 441,3 | -403 | -49,7 | 353,3 |
EBITDA Margin | 506,3 | -407,2 | -40,8 | 366,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 2191 | 78 | -2113 |
Current financial liquidity indicator | 0.6946195363998413 | |||
Net dept to EBITDA | -0.0022937904577702284 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane